Cost-effectiveness analysis of infliximab, adalimumab, golimumab, vedolizumab and tofacitinib for moderate to severe ulcerative colitis in Spain
Trigo-Vicente, Cristina, Gimeno-Ballester, Vicente, López-Del Val, Alejandro
Published in European journal of hospital pharmacy. Science and practice (01.11.2020)
Published in European journal of hospital pharmacy. Science and practice (01.11.2020)
Get full text
Journal Article
Dacomitinib in first-line treatment of advanced EGFR-mutated non-small-cell lung cancer: a cost–effectiveness analysis
Aguilar-Serra, Javier, Gimeno-Ballester, Vicente, Pastor-Clerigues, Alfonso, Milara, Javier, Marti-Bonmati, Ezequiel, Trigo-Vicente, Cristina, Cortijo, Julio
Published in Journal of comparative effectiveness research (01.03.2021)
Published in Journal of comparative effectiveness research (01.03.2021)
Get full text
Journal Article
Cost-effectiveness analysis of infliximab, adalimumab, golimumab and vedolizumab for moderate to severe ulcerative colitis in Spain
Trigo-Vicente, Cristina, Gimeno-Ballester, Vicente, Montoiro-Allué, Raquel, López-Del Val, Alejandro
Published in Expert review of pharmacoeconomics & outcomes research (04.05.2018)
Published in Expert review of pharmacoeconomics & outcomes research (04.05.2018)
Get more information
Journal Article
Osimertinib in first-line treatment of advanced EGFR-mutated non-small-cell lung cancer: a cost–effectiveness analysis
Aguilar-Serra, Javier, Gimeno-Ballester, Vicente, Pastor-Clerigues, Alfonso, Milara, Javier, Marti-Bonmati, Ezequiel, Trigo-Vicente, Cristina, Alós-Almiñana, Manuel, Cortijo, Julio
Published in Journal of comparative effectiveness research (01.08.2019)
Published in Journal of comparative effectiveness research (01.08.2019)
Get full text
Journal Article